HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anesthesia using propofol during surgery of strabismus in children. A comparison of two different protocols of induction and maintenance].

Abstract
The purpose of this study is an investigation of two protocols using propofol as induction and maintenance agent in 100 children scheduled for strabismus surgery (4-8 year, ASA I, NYHA I). Protocol I; Propofol 6 mg.kg-1 in 60 s with fentanyl 2 micrograms.kg-1 and vecuronium bromide 0.08 mg.kg-1 for induction, followed by propofol 11 mg.kg-1 for maintenance; Protocol II; Propofol 3 mg.kg-1 in 20 s with fentanyl 3 micrograms.kg-1 for induction, followed by propofol 12 mg.kg-1.h-1 for maintenance. It appears that the use of protocol I offers significant advantages compared with protocol II: a better quality of induction with a lesser incidence of pain during injection of propofol; a better quality of maintenance with very infrequent bradycardia from oculocardiac reflectivity; and a better recovery with a greatly reduced frequency of nausea and vomiting.
AuthorsM Dandoy, F Poisson, E Lampl, S Reynaud, S Rondet, M N Proust, A Mallet, J P Maurin
JournalCahiers d'anesthesiologie (Cah Anesthesiol) Vol. 38 Issue 4 Pg. 241-5 (Oct 1990) ISSN: 0007-9685 [Print] France
Vernacular TitleAnesthésie au propofol lors de la chirurgie du strabisme chez l'enfant. Comparaison de deux protocoles différents d'induction et d'entretien.
PMID2253060 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Fentanyl
  • Propofol
Topics
  • Anesthesia, Intravenous
  • Child
  • Child, Preschool
  • Fentanyl (administration & dosage)
  • Humans
  • Propofol (administration & dosage)
  • Strabismus (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: